Ausgewählte Publikationen

Vollständige Publikationsliste

Schmidt-Erfurth U, Waldstein SM.

A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.

Prog Retin Eye Res. 2016 Jan;50:1-24. doi: 10.1016/j.preteyeres.2015.07.007. Review.

Schmidt-Erfurth U, Waldstein SM, Deak GG, Kundi M, Simader C.

Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.

Ophthalmology. 2015 Apr;122(4):822-32. doi: 10.1016/j.ophtha.2014.11.017

Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, Heier JS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Korobelnik JF.

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.

Ophthalmology. 2015 Oct;122(10):2044-52. doi: 10.1016/j.ophtha.2015.06.017.

Mylonas G, Georgopoulos M, Malamos P, Georgalas I, Koutsandrea C, Brouzas D, Sacu S, Perisanidis C, Schmidt-Erfurth U; Macula Study Group Vienna.

Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.

Curr Eye Res. 2016 Sep 9:1-5

Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, Eldem B, Monés J, Richard G, Bandello F; European Society of Retina Specialists.

Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).

Br J Ophthalmol. 2014 Sep;98(9):1144-67. doi: 10.1136/bjophthalmol-2014-305702. Review

Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, Ho AC, Ogura Y, Simader C, Jaffe GJ, Slakter JS, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Sowade O, Zeitz O, Norenberg C, Sandbrink R, Heier JS.

Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.

Ophthalmology. 2014 Jan;121(1):193-201. doi: 10.1016/j.ophtha.2013.08.011

Mylonas G, Georgopoulos M, Prinz A, Vock L, Blum RA, Schmidt-Erfurth U.

Influence of a variable overall diameter hydrophilic acrylic sharp-edged single-piece intra-ocular lens on capsule opacification one year after surgery.

Curr Eye Res. 2014 Jun;39(6):620-5. doi: 10.3109/02713683.2013.863939.

Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, Gerstner O, Bouazza AS, Shen H, Osborne A, Mitchell P; RESTORE Extension Study Group.

Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.

Ophthalmology. 2014 May;121(5):1045-53. doi: 10.1016/j.ophtha.2013.11.041

Schmidt-Erfurth U, Eldem B, Guymer R, Korobelnik JF, Schlingemann RO, Axer-Siegel R, Wiedemann P, Simader C, Gekkieva M, Weichselberger A; EXCITE Study Group.

Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study.

Ophthalmology. 2011 May;118(5):831-9. doi: 10.1016/j.ophtha.2010.09.004.

Schmidt-Erfurth U.

Clinical safety of ranibizumab in age-related macular degeneration.

Expert Opin Drug Saf. 2010 Jan;9(1):149-65. doi: 10.1517/14740330903418422. Review

Schmidt-Erfurth UM, Stock G, Pruente C, Ahlers C.

Three-dimensional angiographic imaging of leakage in branch retinal vein occlusion.

Acta Ophthalmol. 2010 Mar;88(2):181-7. doi: 10.1111/j.1755-3768.2008.01390.

Buehl W, Sacu S, Schmidt-Erfurth U.

Retinal vein occlusions.

Dev Ophthalmol. 2010;46:54-72. doi: 10.1159/000320009

Sayegh RG, Georgopoulos M, Geitzenauer W, Simader C, Kiss C, Schmidt-Erfurth U.

High-resolution optical coherence tomography after surgery for vitreomacular traction: a 2-year follow-up.

Ophthalmology. 2010 Oct;117(10):2010-7, 2017.e1-2. doi: 10.1016/j.ophtha.2010.01.041

Schmidt-Erfurth UM, Richard G, Augustin A, Aylward WG, Bandello F, Corcòstegui B, Cunha-Vaz J, Gaudric A, Leys A, Schlingemann RO; European Society for Retina Specialists’ Guidelines Committee (EURETINA).

Guidance for the treatment of neovascular age-related macular degeneration.

Acta Ophthalmol Scand. 2007 Aug;85(5):486-94. Review

Schmidt-Erfurth UM, Pruente C.

Management of neovascular age-related macular degeneration.

Prog Retin Eye Res. 2007 Jul;26(4):437-51. Review

Schmidt-Erfurth U, Kriechbaum K, Oldag A.

Three-dimensional angiography of classic and occult lesion types in choroidal neovascularization.

Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1751-60

Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S.

Time course and morphology of vascular effects associated with photodynamic therapy.

Ophthalmology. 2005 Dec;112(12):2061-9

Schmidt-Erfurth U, Leitgeb RA, Michels S, Povazay B, Sacu S, Hermann B, Ahlers C, Sattmann H, Scholda C, Fercher AF, Drexler W.

Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases.

Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3393-402

Schmidt-Erfurth U.

Nutrition and retina.

Dev Ophthalmol. 2005;38:120-47. Review

Shahrian Varnousfaderani E, Wu J, Vogl WD, Philip AM, Montuoro A, Leitner R, Simader C, Waldstein SM, Gerendas BS, Schmidt-Erfurth U.

A novel benchmark model for intelligent annotation of spectral-domain optical coherence tomography scans using the example of cyst annotation.

Comput Methods Programs Biomed. 2016 Jul;130:93-105. doi: 10.1016/j.cmpb.2016.03.012

Waldstein SM, Simader C, Staurenghi G, Chong NV, Mitchell P, Jaffe GJ, Lu C, Katz TA, Schmidt-Erfurth U.

Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.

Ophthalmology. 2016 Jul;123(7):1521-9. doi: 10.1016/j.ophtha.2016.03.037

Mitsch C, Fehre K, Prager S, Scholda C, Kriechbaum K, Wrba T, Schmidt-Erfurth U

Clinical Decision Support for the Classification of Diabetic Retinopathy: A Comparison of Manual and Automated Results.

Stud Health Technol Inform. 2016;223:17-24.

Schlanitz FG, Baumann B, Kundi M, Sacu S, Baratsits M, Scheschy U, Shahlaee A, Mittermüller TJ, Montuoro A, Roberts P, Pircher M, Hitzenberger CK, Schmidt-Erfurth U.

Drusen volume development over time and its relevance to the course of age-related macular degeneration.

Br J Ophthalmol. 2017 Feb;101(2):198-203. doi: 10.1136/bjophthalmol-2016-308422

Munk MR, Jampol LM, Simader C, Huf W, Mittermüller TJ, Jaffe GJ, Schmidt-Erfurth U.

Differentiation of Diabetic Macular Edema From Pseudophakic Cystoid Macular Edema by Spectral-Domain Optical Coherence Tomography.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6724-33. doi: 10.1167/iovs.15-17042

Waldstein SM, Wright J, Warburton J, Margaron P, Simader C, Schmidt-Erfurth U.

Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD.

Ophthalmology. 2016 Jan;123(1):60-9. doi: 10.1016/j.ophtha.2015.09.013.

Serbecic N, Aboul-Enein F, Beutelspacher SC, Vass C, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U.

High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years.

PLoS One. 2011;6(5):e19843. doi: 10.1371/journal.pone.0019843

Sayegh RG, Simader C, Scheschy U, Montuoro A, Kiss C, Sacu S, Kreil DP, Prünte C, Schmidt-Erfurth U.

A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.

Ophthalmology. 2011 Sep;118(9):1844-51. doi: 10.1016/j.ophtha.2011.01.043